Revvity, Inc. (RVTY:NYSE) closed at $158.77 on October 23, 2026, up 0.94% on the day. The stock trades 4.5% below its 52-week high of $166.25 and 95.5% above its 52-week low of $81.22. Over the past year, it gained 60.6%. Revvity, Inc. is part of the Capital Goods sector.
In 252 trading sessions since October 23, 2025, RVTY closed higher on 132 days (52%). Its best day was September 15, 2026 (+9.11%) and its worst was April 23, 2026 (-7.56%). It never moved 10% or more in a single session.
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Find more stocks like RVTY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.